| Literature DB >> 35694382 |
Kingsley Ekemiri1,2, Ngozika Ezinne1,2, Khadeejah Kamalodeen2, Keomi Pierre2, Brandon Lalla2, Onyekachukwu Amiebenomo3,4, Diane van Staden1, Ferial Zeried5, Chioma Ekemiri6, Kingsley E Agho7,8,9, Uchechukwu Levi Osuagwu8,9.
Abstract
Background: The increase in online learning during the pandemic has been linked to various ocular complaints. This study determined the prevalence and factors associated with ocular complaints among schoolchildren aged 12-19 years during the COVID-19 lockdown in Trinidad and Tobago (T&T).Entities:
Keywords: Blurred vision; Computer; Coronavirus; Digital device; Double vision; E-Learning; Eye health; Headache; Refractive error; Trinidad
Year: 2022 PMID: 35694382 PMCID: PMC9179615 DOI: 10.7717/peerj.13334
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 3.061
Figure 1The contextual framework showing the dependent and independent variables.
Characteristics of the study sample including treatment type and frequency of digital device use.
| Variables | Frequency, |
|---|---|
| Socio-demographic factors | |
| Age category, years | |
| 12–13 | 70 (16.1) |
| 14–15 | 196 (45.1) |
| 16–17 | 111 (25.5) |
| 18–19 | 58 (13.3) |
| Gender | |
| Boys | 206 (47.4) |
| Girls | 220 (50.6) |
| Unspecified | 9 (2.1) |
| Nature of community | |
| Rural | 179 (41.2) |
| Urban | 256 (58.8) |
| Ethnicity | |
| Afro-Trinidad | 73 (16.8) |
| Indo-Trinidad | 214 (49.2) |
| Mixed | 108 (24.8) |
| Others | 40 (9.2) |
| Class Level | |
| Form 1–3 | 236 (54.3) |
| Form 4–6 | 199 (45.7) |
| Average daily hours spent on a digital device | |
| <2 h | 36 (8.3) |
| 2–4 h | 37 (8.5) |
| 4–6 h | 257 (59.1) |
| >6 h | 105 (24.1) |
| Behavioural factor: Posture | |
|
| |
| No | 380 (87.4) |
| Yes | 55 (12.6) |
|
| |
| No | 119 (27.4) |
| Yes | 316 (72.6) |
|
| |
| No | 389 (89.4) |
| Yes | 46 (10.6) |
| Prevention strategies | |
|
| |
| No | 286 (65.8) |
| Yes | 149 (34.2) |
| Interventions | |
|
| |
| Spectacles | 157 (36.1) |
| Medication | 49 (11.3) |
| No treatment | 229 (52.6) |
|
| |
| No | 330 (75.9) |
| Yes | 105 (24.1) |
|
| |
| No | 61 (18.2) |
| Yes | 274 (81.8) |
Notes:
Those with updated spectacles or newly prescribed.
Denominator was number of those with ocular complaints (n = 335).
n, Number of subjects; %, Percentage.
Figure 2Prevalence and 95% confidence intervals (CI) of ocular complaints from e-learning among school children during the lockdown in Trinidad and Tobago.
Figure 3Percentage distribution of actions taken by school children to resolve ocular complaints from e-learning during the lockdown in Trinidad and Tobago.
Prevalence and 95% confidence intervals of dry eyes, headaches, and blurred vision ocular complaints during COVID-19 lockdown among schoolchildren age 12–19 years.
| Variables | Dry eyes | F, | Headache | F, | Blurred vision | F, |
|---|---|---|---|---|---|---|
| Socio-demographic factors | ||||||
| Age category, years | ||||||
| 12–13 | 42.37 [29.64–56.21] | 5.273, | 56.90 [44.46–68.52] | 5.284, | 47.06 [33.48–61.08] | 3.249, |
| 14–15 | 57.45 [49.85–64.70] | 74.70 [66.61–81.38] | 63.93 [54.48–72.42] | |||
| 16–17 | 53.49 [43.57–63.14] | 77.45 [69.52–83.80] | 72.15 [61.72–80.64] | |||
| 18–19 | 75.93 [62.29–85.76] | 90.74 [76.46–96.73] | 76.74 [60.06–87.87] | |||
| Gender | ||||||
| Boys | 50.64 [42.65–58.60] | 4.321, | 67.43 [60.25–73.87] | 10.175, | 53.08 [45.61–60.41] | 15.108, |
| Girls | 62.50 [53.65–70.59] | 82.32 [76.33–87.06] | 76.28 [69.43–82.00] | |||
| Nature of community | ||||||
| Rural | 54.29 [46.03–62.31] | 0.702, | 72.05 [65.24–77.97] | 1.264, | 60.63 [53.81–67.06] | 2.640, |
| Urban | 58.50 [51.15–65.49] | 77.17 [71.21–82.2] | 68.45 [62.62–73.75] | |||
| Ethnicity | ||||||
| Afro-Trinidad | 50.00 [38.31–61.69] | 0.802, | 75.38 [62.29–85.02] | 0.811, | 66.67 [52.74–78.19] | 2.029, |
| Indo-Tri | 60.98 [50.27–70.72] | 78.65 [70.48–85.04] | 68.35 [60.71–75.11] | |||
| Mixed | 55.81 [43.32–67.61] | 70.71 [60.82–78.96] | 65.48 [53.49–75.77] | |||
| Others | 50.00 [34.96–65.04] | 68.42 [51.48–81.57] | 38.10 [18.64–62.31] | |||
| Year in school | ||||||
| Form 1–3 | 50.57 [43.80–57.32] | 6.527, | 70.05 [63.95–75.52] | 4.659, | 58.08 [50.54–65.23] | 4.563, |
| Form 4–6 | 63.41 [54.83–71.22] | 80.33 [73.50–85.74] | 72.86 [63.99–80.22] | |||
| Average daily hours spent on digital device | ||||||
| <2 h | 34.62 [18.50–55.25] | 2.357, | 62.50 [43.30–78.44] | 1.954, | 57.69 [38.22–75.04] | 0.363, |
| 2–4 h | 50.00 [31.31–68.69] | 65.52 [49.62–78.57] | 64.00 [43.39–80.48] | |||
| 4–6 h | 57.79 [50.44–64.81] | 77.63 [72.56–81.99] | 64.91 [59.85–69.66] | |||
| >6 h | 62.37 [51.10–72.43] | 76.00 [67.87–82.60] | 68.49 [57.90–77.46] | |||
| Behavioural factor: Posture | ||||||
| Lying down | ||||||
| No | 53.61 [47.11–59.99] | 7.468, | 73.86 [69.63–90.87] | 1.603, | 63.78 [59.78–67.60] | 1.556, |
| Yes | 75.51 [60.26–86.25] | 82.35 [68.64–90.87] | 73.17 [58.15–84.26] | |||
| Sitting | ||||||
| No | 65.66 [55.26–74.74] | 4.218, | 79.61 [73.07–84.89] | 2.507, | 69.66 [61. 27–76.92] | 1.711, |
| Yes | 53.11 [45.74–60.35] | 73.29 [68.31–77.73] | 63.11 [58.38–67.60] | |||
| Sitting & Lying down | ||||||
| No | 57.65 [51.73–63.36] | 7.468, | 74.19 [69.67–78.25] | 1.603, | 64.26 [60.29–68.04] | 1.711, |
| Yes | 48.48 [32.19–65.11] | 82.05 [68.29–90.66] | 71.88 [57.96–82.57] | |||
| Prevention strategies | ||||||
| Wears glasses | ||||||
| No | 53.98 [47.25–60.57] | 2.491, | 74.80 [69.79–79.34] | 0.0163, | 65.08 [59.71–70.10] | 0.000, |
| Yes | 62.28 [52.77–70.93] | 75.38 [67.69–81.74] | 65.09 [54.92–74.06] | |||
| Interventions | ||||||
| Spectacles | 66.96 [57.98–4.85] | 6.968, | 83.82 [78.09–88.28] | 10.162, | 72.48 [64.67–79.12] | 5.000, |
| Medications | 71.43 [52.13–85.16] | 84.62 [72.11–92.12] | 75.00 [58.54–86.44] | |||
| None | 47.89 [40.59–55.29] | 67.32 [61.46–72. 68] | 57.79 [52.56–62.86] | |||
|
| ||||||
| No | 47.92 [41.51–54.41] | 32.356, | 68.99 [64.77–72.91] | 35.490, | 56.81 [52.19–61.31] | 37.036, |
| Yes | 88.00 [77.40–94.01] | 93.55 [87.18–96.87] | 86.59 [79.32–91.57] | |||
|
| ||||||
| No | 49.36 [42.60–56.14] | 14.113, | 66.72 [61.00–71.15] | 18.219, | 54.90 [50.29–59.43] | 19.653, |
| Yes | 72.90 [61.97–81.62] | 91.60 [83.13–96.02] | 87.91 [76.50–94.20] |
Note:
p–values are significant (sig.) from chi–square test at 5%, F values are shown and the degree of freedom df = 42 except for hours spent on digital devices.
Prevalence and 95% confidence intervals of double vision, itchy eyes and any ocular complaints during COVID-19 lockdown among schoolchildren age 12–19 years.
| Variables | Double vision | F, | Itchy eyes | F, | Any ocular | F, |
|---|---|---|---|---|---|---|
| Socio-demographic factors | ||||||
| Age category, years | ||||||
| 12–13 | 30.00 [17.57–46.28] | 1.133, | 45.45 [31.06–60.65] | 1.682, | 62.86 [50.46–73.76] | 5.384, |
| 14–15 | 32.11 [24.15–41.26] | 43.05 [35.86–50.54] | 76.02 [70.07–81.10] | |||
| 16–17 | 32.05 [22.55–43.31] | 44.44 [33.85–55.57] | 79.28 [69.77–86.38] | |||
| 18–19 | 48.15 [31.22–65.52] | 61.22 [48.41–2.65] | 94.83 [84.87–98.36] | |||
| Gender | ||||||
| Boys | 25.83 [18.50–34.83] | 4.719, | 40.65 [33.53–48.18] | 5.860, | 72.33 [66.94–77.14] | 5.255, |
| Girls | 41.09 [30.94–52.04] | 52.20 [45.66–58.66] | 82.27 [76.45–86.90] | |||
| Nature of community | ||||||
| Rural | 27.78 [20.82–36.01] | 5.124, | 42.86 [34.78–51.34] | 1.150, | 72.07 [66.14–77.31] | 6.549, |
| Urban | 37.67 [30.32–45.64] | 48.78 [42.05–55.56] | 80.86 [77.08–84.15] | |||
| Ethnicity | ||||||
| Afro-Trinidad | 33.33 [21.05–48.39] | 0.364, | 39.62 [27.54–53.12] | 0.655, | 76.71 [66.28–84.66] | 1.532, |
| Indo-Tri | 35.14 [25.29–45.14] | 49.1 [40.67–57.59] | 80.84 [74.47–85.92] | |||
| Mixed | 34.29 [23.57–46.88] | 47.83 [37.29–58.56] | 75.00 [65.34–82.68] | |||
| Others | 24.00 [10.24–46.63] | 39.39 [23.98–57.26] | 65.00 [49.86–77.62] | |||
| Year in school | ||||||
| Form 1–3 | 32.37 [25.41–40.21] | 0.169, | 43.48 [36.66–50.55] | 1.238, | 71.61 [66.66–76.09] | 8.759, |
| Form 4–6 | 34.78 [25.55–45.32] | 49.69 [41.60–57. 80] | 83.92 [78.56–88.14] | |||
| Average daily hours spent on DD | ||||||
| <2 h | 40.00 [24.10–58.33] | 1.784, | 32.00 [15.87–54.00] | 1.954, | 69.44 [52.58–82.33] | 1.261, |
| 2–4 h | 18.18 [6.58–41.20] | 38.46 [23.27–56.29] | 67.57 [50.35–81.06] | |||
| 4–6 h | 30.43 [22.36–39.93] | 47.26 [40.96–53.65] | 78.60 [74.79–81.97] | |||
| >6 h | 42.03 [29.84–55.28] | 50.54 [39.39–61.63] | 80.00 [70.48–87.01] | |||
| Behavioural factor: Posture | ||||||
| Lying down | ||||||
| No | 30.36 [24.85–36.50] | 8.426, | 43.42[38.23–48.76] | 11.113, | 76.58 [73.24–79.62] | 0.817, |
| Yes | 56.67 [36.88–74.53] | 68.29 [54.09–79.74] | 81.82 [70.31–89.53] | |||
| Sitting | ||||||
| No | 45.45 [32.83–58.69] | 6.283, | 54.35 [44.27–64.08] | 3.162, | 79.83 [73.15–85.19] | 0.711, |
| Yes | 29.26 [23.29–36.03] | 43.48 [37.40–49.76] | 76.27 [72.09–79.99] | |||
| Sitting & Lying down | ||||||
| No | 33.78 [27.19–41.07] | 8.426, | 46.93 [41.36–52.57] | 11.113, | 76.61 [73.32–79.60] | 0.817, |
| Yes | 31.03 [16.90–49.90] | 41.67 [27.78–57.02] | 82.61 [70.18–90.56] | |||
| Prevention strategies | ||||||
| Wears glasses | ||||||
| No | 33.92 [26.88–41.75] | 0.053, | 45.33 [39.32–51.48] | 0.234, | 76.57 [72.78–79.98] | 0.817, |
| Yes | 32.53 [23.14–43.58] | 48.33 [38.28–58.52] | 78.52 [71.17–84.41] | |||
| Interventions | ||||||
| Spectacles | 40.7 [30.94–51.25] | 3.132, | 52.94 [43.83–61.86] | 7.648, | 84.71 [79.34–88.88] | 5.049, |
| Medications | 43.48 [23.76–65.50] | 72.97 [51.61–87.24] | 77.55 [64.17–86.95] | |||
| None | 27.59 [21.39–34.78] | 37.04 [30.55–44.02] | 72.05 [67.43–76.25] | |||
|
| ||||||
| No | 28.99 [23.05–35.74] | 9.078, | 40.15[34.87–45.66] | 21.518, | 72.42 [69.35–75.3] | 26.728, |
| Yes | 53.19 [37. 15–68.60] | 68.42 [57.22–77.83] | 92.38 [86.44–95.85] | |||
|
| ||||||
| No | 25.00 [19.24–31.81] | 26.053, | 39.66 [34.90–44.61] | 14.41, | 69.15 [65.09–72.94] | 32.669, |
| Yes | 52.56 [41.39–63.48] | 60.18 [49.63–69.85] | 94.29 [88.88–97.15] |
Notes:
Any ocular symptom.
p–values are significant (sig.) from chi square test at 5%, F values are shown and the degree of freedom df = 42.
Factors associated with ocular complaints during COVID-19 lockdown among. Results are adjusted odds ratios (confidence intervals) from hierarchical multivariate analysis. Only the significant variables are presented.
| Variables | Dry eyes | Blurred vision | Headache | |||
|---|---|---|---|---|---|---|
| Socio-demographic factors | ||||||
| Age category, years | ||||||
| 12–13 | 1.00 | 1.00 | 1.00 | |||
| 14–15 |
|
|
|
|
| 0.002 |
| 16–17 | 1.47 [0.67–3.25] |
|
|
|
| 0.004 |
| 18–19 |
|
|
|
|
| 0.000 |
| Gender | ||||||
| Boys | – | 1.00 | 1.00 | |||
| Girls | – |
|
|
| 0.001 | |
| Ethnicity | ||||||
| Afro-Trinidad | – | 1.00 | – | |||
| Others | – |
| 0.005 | – | ||
| Behavioural factor: Posture | ||||||
|
| ||||||
| No | 1.00 | – | – | |||
| Yes |
|
| – | – | ||
|
| ||||||
| No | 1.00 | – | – | |||
| Yes |
| 0.035 | – | – | ||
| Prevention strategies | ||||||
|
| ||||||
| No | – | 1.00 | 1.00 | |||
| Yes | – |
|
|
|
| |
| Interventions | ||||||
|
| ||||||
| No | 1.00 | 1.00 | 1.00 | |||
| Yes |
|
|
|
|
|
|
|
| ||||||
| No | 1.00 | 1.00 | 1.00 | |||
| Yes |
|
|
|
|
|
|
Note:
Bolded confidence intervals are significant variables. Empty cells are non–significant variables in the unadjusted analysis.
Factors associated with ocular complaints during COVID-19 lockdown among. Results are adjusted odds ratios (confidence intervals) from hierarchical multivariate analysis. Only the significant variables are presented.
| Variables | Double vision | Itchy eyes | Any ocular | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Socio-demographic factors | ||||||||||
| Age category, years | ||||||||||
| 12–13 | 1.00 | |||||||||
| 14–15 | – | – |
|
| ||||||
| 16–17 | – | – |
|
| ||||||
| 18–19 | – | – |
|
| ||||||
| Gender | ||||||||||
| Boys | – | – | – | – | ||||||
| Girls | – | – | – | – | ||||||
| Behavioural factor: Posture | ||||||||||
|
| ||||||||||
| No | 1.00 | – | – | |||||||
| Yes |
| 0.001 | – | – | ||||||
|
| ||||||||||
| No | 1.00 | – | – | – | – | |||||
| Yes |
| 0.001 | – | – | – | – | ||||
|
| ||||||||||
| No | 1.00 | – | – | – | ||||||
| Yes |
| 0.014 | – | – | – | |||||
| Prevention strategies | ||||||||||
|
| ||||||||||
| No | – | 1.00 | – | 1.00 | ||||||
| Yes |
|
|
|
|
| |||||
|
| ||||||||||
| Spectacles | – | 1.00 | 1.00 | |||||||
| Medications | – |
| 0.026 | 0.32 [0.11–0.93] | 0.036 | |||||
|
| ||||||||||
| No | 1.00 | 1.00 | 1.00 | |||||||
| Yes |
|
|
|
|
|
| ||||
|
| ||||||||||
| No | 1.00 | – | – | 1.00 | ||||||
| Yes |
|
| – | – |
|
| ||||
Notes:
Any ocular symptom.
Bolded confidence intervals are significant variables. Empty cells are non−significant variables in the unadjusted analysis.